{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:34:20Z","timestamp":1792625660595,"version":"4.5.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01081-x","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:30:10Z","timestamp":1760722210000},"page":"809-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comprehensive global review on pharmacist-led strategies to support medication therapy in hypertensive patients"],"prefix":"10.1038","volume":"39","author":[{"given":"Rabeel","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-9826","authenticated-orcid":false,"given":"Muhammad Ahsan","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/ijpp\/riad013","volume":"31","author":"S Al-Arkee","year":"2023","unstructured":"Al-Arkee S, Al-Ani O. Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular disease: a systematic review of randomised controlled trials. Int J Pharm Pract. 2023;31:269\u201375.","journal-title":"Int J Pharm Pract"},{"key":"1081_CR2","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.2018.16760","volume":"320","author":"ND Fisher","year":"2018","unstructured":"Fisher ND, Curfman G. Hypertension\u2014a public health challenge of global proportions. JAMA. 2018;320:1757\u20139.","journal-title":"JAMA"},{"key":"1081_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/PPA.S191482","volume":"13","author":"RL Cutler","year":"2019","unstructured":"Cutler RL, Torres-Robles A, Wiecek E, Drake B, Van der Linden N, Benrimoj SIC, et al. Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system. Patient Prefer Adherence. 2019;13:853\u201362.","journal-title":"Patient Prefer Adherence"},{"key":"1081_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bcp.15514","volume":"89","author":"EE Ayogu","year":"2023","unstructured":"Ayogu EE, Yahaya RI, Isah A, Ubaka CM. Effectiveness of a pharmacist\u2010led educational intervention on health outcomes in hypertension management at community pharmacies in Nigeria: a two\u2010arm parallel single\u2010blind randomized controlled trial. Br J Clin Pharmacol. 2023;89:649\u201359.","journal-title":"Br J Clin Pharmacol"},{"key":"1081_CR5","doi-asserted-by":"publisher","first-page":"e11121","DOI":"10.1097\/MD.0000000000011121","volume":"97","author":"T Milman","year":"2018","unstructured":"Milman T, Joundi RA, Alotaibi NM, Saposnik G. Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e11121.","journal-title":"Medicine (Baltimore)"},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ahj.2011.06.007","volume":"162","author":"HB Bosworth","year":"2011","unstructured":"Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, et al. Medication adherence: a call for action. Am Heart J. 2011;162:412\u201324.","journal-title":"Am Heart J"},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.","journal-title":"BMJ"},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/17437199.2010.537592","volume":"6","author":"MR DiMatteo","year":"2012","unstructured":"DiMatteo MR, Haskard-Zolnierek KB, Martin LR. Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 2012;6:74\u201391.","journal-title":"Health Psychol Rev"},{"key":"1081_CR9","doi-asserted-by":"crossref","unstructured":"Kripalani S, Yao X, Haynes RB Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167:540\u20139.","DOI":"10.1001\/archinte.167.6.540"},{"key":"1081_CR10","doi-asserted-by":"publisher","first-page":"e0219266","DOI":"10.1371\/journal.pone.0219266","volume":"14","author":"D Macquart de Terline","year":"2019","unstructured":"Macquart de Terline D, Kane A, Kramoh KE, Ali Toure I, Mipinda JB, Diop IB, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS ONE. 2019;14:e0219266.","journal-title":"PLoS ONE"},{"key":"1081_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-019-1014-8","volume":"8","author":"A Gast","year":"2019","unstructured":"Gast A, Mathes T. Medication adherence influencing factors\u2014an (updated) overview of systematic reviews. Syst Rev. 2019;8:1\u201317.","journal-title":"Syst Rev"},{"key":"1081_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0145721714523684","volume":"40","author":"MF Magee","year":"2014","unstructured":"Magee MF, Khan NH, Desale S, Nassar CM. Diabetes to go: knowledge-and competency-based hospital survival skills diabetes education program improves postdischarge medication adherence. Diabetes Educ. 2014;40:344\u201350.","journal-title":"Diabetes Educ"},{"key":"1081_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","volume":"176","author":"J Thakkar","year":"2016","unstructured":"Thakkar J, Kurup R, Laba TL, Santo K, Thiagalingam A, Rodgers A, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176:340\u20139.","journal-title":"JAMA Intern Med"},{"key":"1081_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10916-015-0224-4","volume":"39","author":"KT Win","year":"2015","unstructured":"Win KT, Hassan NM, Bonney A, Iverson D. Benefits of online health education: perception from consumers and health professionals. J Med Syst. 2015;39:1\u20138.","journal-title":"J Med Syst"},{"key":"1081_CR15","first-page":"589","volume":"46","author":"HTV Zomahoun","year":"2017","unstructured":"Zomahoun HTV, Gu\u00e9nette L, Gr\u00e9goire JP, Lauzier S, Lawani AM, Ferdynus C, et al. Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. Int J Epidemiol. 2017;46:589\u2013602.","journal-title":"Int J Epidemiol"},{"key":"1081_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11096-012-9713-4","volume":"35","author":"IA Basheti","year":"2013","unstructured":"Basheti IA, Qunaibi EA, Bulatova NR, Samara S, AbuRuz S. Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews. Int J Clin Pharm. 2013;35:92\u2013100.","journal-title":"Int J Clin Pharm"},{"key":"1081_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/jpri\/2024\/v36i107584","volume":"36","author":"Z Asif","year":"2024","unstructured":"Asif Z, Virk AA, Alvi AS, Bibi I, Iqbal M, Amish, et al. Evaluating patient perceptions of pharmacist-led medication therapy management in hypertension management. J Pharm Res Int. 2024;36:1\u201313.","journal-title":"J Pharm Res Int"},{"key":"1081_CR18","doi-asserted-by":"crossref","unstructured":"Marupuru S, Roether A, Guimond AJ, Stanley C, Pesqueira T, Axon DR. A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. in Healthcare. 2022. MDPI.","DOI":"10.3390\/healthcare10071207"},{"key":"1081_CR19","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.5888\/pcd17.200058","volume":"17","author":"H Thompson","year":"2020","unstructured":"Thompson H, Swander L, Cohen R, Lukazewski A, Bartholow T, Pesik M, et al. Hypertension-focused medication therapy management: a collaborative pilot program uniting pharmacists, public health, and health insurers in Wisconsin. Prev Chronic Dis. 2020;17:E105.","journal-title":"Prev Chronic Dis"},{"key":"1081_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4066\/AMJ.2014.2133","volume":"7","author":"S Sharma","year":"2014","unstructured":"Sharma S, Kc B, Alrasheedy AA, Kaundinnyayana A, Khanal A. Impact of community pharmacy-based educational intervention on patients with hypertension in Western Nepal. Australas Med J. 2014;7:304\u201313.","journal-title":"Australas Med J"},{"key":"1081_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1357633X221076719","volume":"28","author":"MN Vel\u00e1zquez Fuentes","year":"2022","unstructured":"Vel\u00e1zquez Fuentes MN, Shah P, Hale GM. Improving medication adherence in patients with hypertension through pharmacist-led telehealth services. J Telemed Telecare. 2022;28:613\u20137.","journal-title":"J Telemed Telecare"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/jac5.1486","volume":"4","author":"T Melton","year":"2021","unstructured":"Melton T, Jasmin H, Johnson HF, Coley A, Duffey S, Renfro CP. Describing the delivery of clinical pharmacy services via telehealth: a systematic review. J Am Coll Clin Pharm. 2021;4:994\u20131010.","journal-title":"J Am Coll Clin Pharm"},{"key":"1081_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1751-7176.2011.00542.x","volume":"14","author":"BL Carter","year":"2012","unstructured":"Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens. 2012;14:51\u201365.","journal-title":"J Clin Hypertens"},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.9745\/GHSP-D-20-00505","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, Liu G, Liu C, Wang X, Chu Y, Li X, et al. Effects of pharmacist intervention on community control of hypertension: a randomized controlled trial in Zunyi, China. Glob Health Sci Pract. 2021;9:890\u2013904.","journal-title":"Glob Health Sci Pract"},{"key":"1081_CR25","first-page":"68","volume":"7","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS. Acc\/aha\/aapa\/abc\/acpm\/ags\/APhA\/ASH\/ASPC\/nma\/pcna guideline for the prevention, Detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology\/American heart Association. Task force on clinical practice guidelines. J Am Coll Cardiol-2017.-Nov 13. \u041f\u043e\u0447\u043a\u0438. 2018;7:68\u201374.","journal-title":"J Am Coll Cardiol-2017.-Nov 13. \u041f\u043e\u0447\u043a\u0438"},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.15585\/mmwr.mm6545a3","volume":"65","author":"R Merai","year":"2016","unstructured":"Merai R. CDC grand rounds: a public health approach to detect and control hypertension. MMWR Morb Mortal Wkly Rep. 2016;65:1261\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1081_CR27","doi-asserted-by":"crossref","unstructured":"Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024;47:1099\u2013102.","DOI":"10.1038\/s41440-024-01622-w"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u201399.","journal-title":"Pharmacol Res"},{"key":"1081_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/HJH.0000000000002294","volume":"38","author":"NR Poulter","year":"2020","unstructured":"Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, et al. Medication adherence in hypertension. J Hypertens. 2020;38:579\u201387.","journal-title":"J Hypertens"},{"key":"1081_CR30","doi-asserted-by":"publisher","first-page":"e8015","DOI":"10.7717\/peerj.8015","volume":"7","author":"H Song","year":"2019","unstructured":"Song H, Feng D, Wang R, Yang J, Li Y, Gao J, et al. The urban-rural disparity in the prevalence and risk factors of hypertension among the elderly in China\u2014a cross-sectional study. PeerJ. 2019;7:e8015.","journal-title":"PeerJ"},{"key":"1081_CR31","unstructured":"Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2020;2017\u20132018."},{"key":"1081_CR32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.5114\/aoms.2020.92689","volume":"16","author":"E Wierzejska","year":"2020","unstructured":"Wierzejska E, Gierna\u015b B, Lipiak A, Karasiewicz M, Cofta M, Staszewski R. A global perspective on the costs of hypertension: a systematic review. Arch Med Sci. 2020;16:1078\u201391.","journal-title":"Arch Med Sci"},{"key":"1081_CR33","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.2147\/PPA.S368784","volume":"16","author":"SM Hamrahian","year":"2022","unstructured":"Hamrahian SM, Maarouf OH, F\u00fcl\u00f6p T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Prefer Adherence. 2022;16:2749\u201357.","journal-title":"Patient Prefer Adherence"},{"key":"1081_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","volume":"25","author":"MA Fischer","year":"2010","unstructured":"Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284\u201390.","journal-title":"J Gen Intern Med"},{"key":"1081_CR35","doi-asserted-by":"crossref","unstructured":"Solomon MD, Majumdar SR. Primary non-adherence of medications: lifting the veil on prescription-filling behaviors. J Gen Intern Med. 2010;25:280\u20131.","DOI":"10.1007\/s11606-010-1286-0"},{"key":"1081_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40520-015-0516-z","volume":"28","author":"Y Hou","year":"2016","unstructured":"Hou Y, Zhang D, Gu J, Xue F, Sun Y, Wu Q, et al. The association between self-perceptions of aging and antihypertensive medication adherence in older Chinese adults. Aging Clin Exp Res. 2016;28:1113\u201320.","journal-title":"Aging Clin Exp Res"},{"key":"1081_CR37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","volume":"21","author":"KC Farmer","year":"1999","unstructured":"Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074\u201390.","journal-title":"Clin Ther"},{"key":"1081_CR38","unstructured":"Cramer JA, Spilker B. Patient compliance in medical practice and clinical trials. 1991."},{"key":"1081_CR39","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1016\/S0197-2456(00)00077-5","volume":"21","author":"MZ Vitolins","year":"2000","unstructured":"Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21:S188\u2013S194.","journal-title":"Control Clin Trials"},{"key":"1081_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331\u201342.","journal-title":"J Clin Pharm Ther"},{"key":"1081_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26:155.","journal-title":"Oman Med J"},{"key":"1081_CR42","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","volume":"119","author":"PM Ho","year":"2009","unstructured":"Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028\u201335.","journal-title":"Circulation"},{"key":"1081_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00002030-200201250-00017","volume":"16","author":"JC Walsh","year":"2002","unstructured":"Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269\u201377.","journal-title":"AIDS"},{"key":"1081_CR44","doi-asserted-by":"publisher","first-page":"e0187139","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS ONE. 2017;12:e0187139.","journal-title":"PLoS ONE"},{"key":"1081_CR45","doi-asserted-by":"crossref","unstructured":"Li\u2010Wan\u2010Po A, Peterson GM. Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning. J Clin Pharm Ther. 2021;46:1\u20133.","DOI":"10.1111\/jcpt.13325"},{"key":"1081_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol. 2020;86:1281\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1081_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/21556660.2019.1579729","volume":"8","author":"AA Naqvi","year":"2019","unstructured":"Naqvi AA, Hassali MA, Jahangir A, Nadir MN, Kachela B. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses. J Drug Assess. 2019;8:36\u201342.","journal-title":"J Drug Assess"},{"key":"1081_CR48","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fphar.2018.01124","volume":"9","author":"AA Naqvi","year":"2018","unstructured":"Naqvi AA, Hassali MA, Rizvi M, Zehra A, Iffat W, Haseeb A, et al. Development and validation of a novel general medication adherence scale (GMAS) for chronic illness patients in Pakistan. Front Pharmacol. 2018;9:1124.","journal-title":"Front Pharmacol"},{"key":"1081_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1751-7117.2000.tb00211.x","volume":"15","author":"MT Kim","year":"2000","unstructured":"Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90\u20136.","journal-title":"Prog Cardiovasc Nurs"},{"key":"1081_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jehp.jehp_65_16","volume":"7","author":"A Najimi","year":"2018","unstructured":"Najimi A, Mostafavi F, Sharifirad G, Golshiri P. Barriers to medication adherence in patients with hypertension: a qualitative study. J Educ Health Promot. 2018;7:24.","journal-title":"J Educ Health Promot"},{"key":"1081_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.jhh.1002046","volume":"20","author":"J Mant","year":"2006","unstructured":"Mant J, McManus R. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens. 2006;20:551\u20133.","journal-title":"J Hum Hypertens"},{"key":"1081_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.47203\/IJCH.2020.v32i01.025","volume":"32","author":"MK Goel","year":"2020","unstructured":"Goel MK. Non-adherence to anti-hypertensive treatment. Indian J Community Health. 2020;32:126\u20139.","journal-title":"Indian J Community Health"},{"key":"1081_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2147\/PPA.S238751","volume":"14","author":"H Abbas","year":"2020","unstructured":"Abbas H, Kurdi M, de Vries F, van Onzenoort HAW, Driessen JHM, Watfa M, et al. Factors associated with antihypertensive medication non-adherence: a cross-sectional study among lebanese hypertensive adults. Patient Prefer Adherence. 2020;14:663\u201373.","journal-title":"Patient Prefer Adherence"},{"key":"1081_CR54","first-page":"e59532","volume":"16","author":"PD Ferreira Jr","year":"2024","unstructured":"Ferreira PD Jr, Simoes JA Sr., Velho DC Sr. Adherence to antihypertensive therapy and its determinants: a systematic review. Cureus. 2024;16:e59532.","journal-title":"Cureus"},{"key":"1081_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4236\/ojcd.2021.112002","volume":"11","author":"C Gikunda","year":"2021","unstructured":"Gikunda C, Gitonga L, Kamweru P. Patient and health system related factors associated with non-adherence to antihypertensive medication among patients at Chuka Referral Hospital, Kenya. Open J Clin Diagn. 2021;11:19.","journal-title":"Open J Clin Diagn"},{"key":"1081_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/2010105820933305","volume":"29","author":"GCY Kang","year":"2020","unstructured":"Kang GCY, Koh EYL, Tan NC. Prevalence and factors associated with adherence to anti-hypertensives among adults with hypertension in a developed Asian community: a cross-sectional study. Proc Singapore Healthc. 2020;29:167\u201375.","journal-title":"Proc Singapore Healthc"},{"key":"1081_CR57","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s11606-020-06447-0","volume":"36","author":"ME Wilder","year":"2021","unstructured":"Wilder ME, Kulie P, Jensen C, Levett P, Blanchard J, Dominguez LW, et al. The impact of social determinants of health on medication adherence: a systematic review and meta-analysis. J Gen Intern Med. 2021;36:1359\u201370.","journal-title":"J Gen Intern Med"},{"key":"1081_CR58","first-page":"181","volume":"5","author":"F Alsolami","year":"2015","unstructured":"Alsolami F, Correa-Velez I, Hou X-Y. Factors affecting antihypertensive medications adherence among hypertensive patients in Saudi Arabia. Am J Med Med Sci. 2015;5:181\u20139.","journal-title":"Am J Med Med Sci"},{"key":"1081_CR59","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2146\/ajhp060162","volume":"63","author":"MG Katz","year":"2006","unstructured":"Katz MG, Kripalani S, Weiss BD. Use of pictorial aids in medication instructions: a review of the literature. Am J Health Syst Pharm. 2006;63:2391\u20137.","journal-title":"Am J Health Syst Pharm"},{"key":"1081_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.sapharm.2009.01.004","volume":"5","author":"C Magadza","year":"2009","unstructured":"Magadza C, Radloff S, Srinivas S. The effect of an educational intervention on patients\u2019 knowledge about hypertension, beliefs about medicines, and adherence. Res Social Adm Pharm. 2009;5:363\u201375.","journal-title":"Res Social Adm Pharm"},{"key":"1081_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clinthera.2011.02.003","volume":"33","author":"BK Zedler","year":"2011","unstructured":"Zedler BK, Kakad P, Colilla S, Murrelle L, Shah NR. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33:62\u201373.","journal-title":"Clin Ther"},{"key":"1081_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3821\/1913-701X-142.1.28","volume":"142","author":"ON Gould","year":"2009","unstructured":"Gould ON, Todd L, Irvine-Meek J. Adherence devices in a community sample: how are pillboxes used? Canadian Pharmacists Journal\/Revue des Pharmaciens du Canada. 2009;142:28\u201335.","journal-title":"Canadian Pharmacists Journal\/Revue des Pharmaciens du Canada"},{"key":"1081_CR63","doi-asserted-by":"publisher","first-page":"eAO6011","DOI":"10.31744\/einstein_journal\/2021AO6011","volume":"19","author":"LB Vieira","year":"2021","unstructured":"Vieira LB, Reis AMM, Ramos C\u00c1, Reis TMD, Cassiani SHB. The use of an electronic medication organizer device with alarm to improve medication adherence of older adults with hypertension. Einstein (Sao Paulo). 2021;19:eAO6011.","journal-title":"Einstein (Sao Paulo)"},{"key":"1081_CR64","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","volume":"31","author":"KS Ingersoll","year":"2008","unstructured":"Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31:213\u201324.","journal-title":"J Behav Med"},{"key":"1081_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-6209-8","volume":"18","author":"P Dillon","year":"2018","unstructured":"Dillon P, Smith SM, Gallagher P, Cousins G. Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population. BMC Public Health. 2018;18:1\u20139.","journal-title":"BMC Public Health"},{"key":"1081_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4103\/ijnmr.IJNMR_16_16","volume":"22","author":"A Haidari","year":"2017","unstructured":"Haidari A, Moeini M, Khosravi A. The impact of peer support program on adherence to the treatment regimen in patients with hypertension: A randomized clinical trial study. Iran J Nurs Midwifery Res. 2017;22:427.","journal-title":"Iran J Nurs Midwifery Res"},{"key":"1081_CR67","doi-asserted-by":"publisher","first-page":"024","DOI":"10.17352\/2455-5479.000021","volume":"3","author":"B Ezeala-Adikaibe","year":"2017","unstructured":"Ezeala-Adikaibe B, Mbadiwe N, Okudo G, Nwosu N, Nwobodo N, Onyebueke G, et al. Factors associated with medication adherence among hypertensive patients in a tertiary health center: a cross-sectional study. Arch Community Med Public Health. 2017;3:024\u2013031.","journal-title":"Arch Community Med Public Health"},{"key":"1081_CR68","first-page":"215","volume":"17","author":"MH Elnaem","year":"2017","unstructured":"Elnaem MH, Jamshed SQ, Elkalmi RM. The future of pharmaceutical care in Malaysia: pharmacy students\u2019 perspectives. Pharmacy Education. 2017;17:215\u201322.","journal-title":"Pharmacy Education"},{"key":"1081_CR69","first-page":"45","volume-title":"The pharmacist\u2019s role in medication adherence","author":"S Albrecht","year":"2011","unstructured":"Albrecht S. The pharmacist\u2019s role in medication adherence. NEW YORK, NY 10013-1678 USA: JOBSON PUBLISHING LLC 100 AVE OF THE AMERICAS; 2011. p. 45\u201348."},{"key":"1081_CR70","unstructured":"Oyeneyin, Y, et al. Copyright 2019 International Pharmaceutical Federation (FIP) International Pharmaceutical Federation (FIP) Andries Bickerweg 5 2517 JP The Hague The Netherlands. 2019."},{"issue":"1","key":"1081_CR71","first-page":"4304761","volume":"2016","author":"PZ Murphy","year":"2016","unstructured":"Murphy PZ, Sands C, Ford F. Effectiveness of a pharmacist\u2010led cardiovascular risk reduction clinic in Rural Perry County, Alabama. Int J Chronic Dis. 2016;2016(1):4304761.","journal-title":"Int J Chronic Dis"},{"key":"1081_CR72","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1046\/j.1525-1497.1998.00225.x","volume":"13","author":"PE Bogden","year":"1998","unstructured":"Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998;13:740\u20135.","journal-title":"J Gen Intern Med"},{"key":"1081_CR73","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/bcp.12452","volume":"78","author":"E Cheema","year":"2014","unstructured":"Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta\u2010analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238\u201347.","journal-title":"Br J Clin Pharmacol"},{"key":"1081_CR74","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2147\/JMDH.S257273","volume":"13","author":"MH Elnaem","year":"2020","unstructured":"Elnaem MH, Rosley NFF, Alhifany AA, Elrggal ME, Cheema E. Impact of pharmacist-led interventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature. J Multidiscip Healthc. 2020;13:635\u201345.","journal-title":"J Multidiscip Healthc"},{"key":"1081_CR75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","volume":"48","author":"MA Chisholm-Burns","year":"2010","unstructured":"Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists\u2019 effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923\u201333.","journal-title":"Med Care"},{"key":"1081_CR76","first-page":"56","volume":"22","author":"A Brummel","year":"2016","unstructured":"Brummel A, Carlson AM. Comprehensive medication management and medication adherence for chronic conditions. J Manag Care Spec Pharm. 2016;22:56\u201362.","journal-title":"J Manag Care Spec Pharm"},{"key":"1081_CR77","doi-asserted-by":"publisher","first-page":"693171","DOI":"10.3389\/fmed.2021.693171","volume":"8","author":"T Kuo","year":"2021","unstructured":"Kuo T, Chen S, Oh SM, Barragan NC, American Heart Association Western States Chronic Disease Prevention and Management Committee. Comprehensive medication management as a standard of practice for managing uncontrolled blood pressure. Front Med. 2021;8:693171.","journal-title":"Front Med"},{"key":"1081_CR78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/pharmacy10050111","volume":"10","author":"LE Knockel","year":"2022","unstructured":"Knockel LE, Kim Y, Kent K, Doucette WR. Medication-related problems and interventions identified and addressed by pharmacists conducting enhanced medication therapy management services. Pharmacy. 2022;10:111.","journal-title":"Pharmacy"},{"key":"1081_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.sapharm.2019.04.010","volume":"16","author":"D Stewart","year":"2020","unstructured":"Stewart D, Whittlesea C, Dhital R, Newbould L, McCambridge J. Community pharmacist led medication reviews in the UK: a scoping review of the medicines use review and the new medicine service literatures. Res Social Adm Pharm. 2020;16:111\u201322.","journal-title":"Res Social Adm Pharm"},{"key":"1081_CR80","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1715163515569571","volume":"148","author":"N Henrich","year":"2015","unstructured":"Henrich N, Tsao N, Gastonguay L, Lynd L, Marra CA. BC medication management project: perspectives of pharmacists, patients and physicians. Can Pharm J\/Revue des Pharmaciens du Canada. 2015;148:90\u2013100.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"key":"1081_CR81","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40266-016-0357-2","volume":"33","author":"TF Chen","year":"2016","unstructured":"Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016;33:199\u2013204.","journal-title":"Drugs Aging"},{"key":"1081_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-019-0946-7","volume":"14","author":"KC Hohmeier","year":"2019","unstructured":"Hohmeier KC, Wheeler JS, Turner K, Vick JS, Marchetti ML, Crain J, et al. Targeting adaptability to improve Medication Therapy Management (MTM) implementation in community pharmacy. Implement Sci. 2019;14:1\u201313.","journal-title":"Implement Sci"},{"key":"1081_CR83","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.clinthera.2014.06.030","volume":"36","author":"JD Hirsch","year":"2014","unstructured":"Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, et al. Primary care\u2013based, pharmacist\u2013physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36:1244\u201354.","journal-title":"Clin Ther"},{"key":"1081_CR84","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11096-010-9474-x","volume":"33","author":"M Morgado","year":"2011","unstructured":"Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33:132\u201340.","journal-title":"Int J Clin Pharm"},{"key":"1081_CR85","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/bmjqs-2018-009177","volume":"29","author":"RA Elliott","year":"2020","unstructured":"Elliott RA, Boyd MJ, Tanajewski L, Barber N, Gkountouras G, Avery AJ, et al. \u2018New Medicine Service\u2019: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial. BMJ Qual Saf. 2020;29:286\u201395.","journal-title":"BMJ Qual Saf"},{"key":"1081_CR86","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/ijpp.12462","volume":"26","author":"A Milosavljevic","year":"2018","unstructured":"Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26:387\u201397.","journal-title":"Int J Pharm Pract"},{"key":"1081_CR87","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.3390\/jcm12083037","volume":"12","author":"M Jasi\u0144ska-Stroschein","year":"2023","unstructured":"Jasi\u0144ska-Stroschein M, Waszyk-Nowaczyk M. Multidimensional interventions on supporting disease management for hospitalized patients with heart failure: the role of clinical and community pharmacists. J Clin Med. 2023;12:3037.","journal-title":"J Clin Med"},{"key":"1081_CR88","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/qshc.2003.005926","volume":"13","author":"N Barber","year":"2004","unstructured":"Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients\u2019 problems with new medication for chronic conditions. BMJ Qual Saf. 2004;13:172\u20135.","journal-title":"BMJ Qual Saf"},{"key":"1081_CR89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0738-3991(87)90093-0","volume":"10","author":"H Leventhal","year":"1987","unstructured":"Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns. 1987;10:117\u201338.","journal-title":"Patient Educ Couns"},{"key":"1081_CR90","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/bmjqs-2015-004400","volume":"25","author":"RA Elliott","year":"2016","unstructured":"Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 2016;25:747\u201358.","journal-title":"BMJ Qual Saf"},{"key":"1081_CR91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2013.6549","volume":"310","author":"KL Margolis","year":"2013","unstructured":"Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46\u201356.","journal-title":"JAMA"},{"key":"1081_CR92","doi-asserted-by":"publisher","first-page":"e000718","DOI":"10.1161\/JAHA.113.000718","volume":"3","author":"V Santschi","year":"2014","unstructured":"Santschi V, Chiolero A, Colosimo AL, Platt RW, Taff\u00e9 P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta\u2010analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.","journal-title":"J Am Heart Assoc"},{"key":"1081_CR93","doi-asserted-by":"crossref","unstructured":"Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T, Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev, 2010.","DOI":"10.1002\/14651858.CD005182.pub4"},{"key":"1081_CR94","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1197\/jamia.M2270","volume":"14","author":"G Par\u00e9","year":"2007","unstructured":"Par\u00e9 G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc. 2007;14:269\u201377.","journal-title":"J Am Med Inform Assoc"},{"key":"1081_CR95","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1370\/afm.2491","volume":"18","author":"SJ Patil","year":"2020","unstructured":"Patil SJ, Wareg NK, Hodges KL, Smith JB, Kaiser MS, LeFevre ML. Home blood pressure monitoring in cases of clinical uncertainty to differentiate appropriate inaction from therapeutic inertia. Ann Fam Med. 2020;18:50\u201358.","journal-title":"Ann Fam Med"},{"key":"1081_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-019-0916-0","volume":"21","author":"N Liyanage-Don","year":"2019","unstructured":"Liyanage-Don N, Fung D, Phillips E, Kronish IM. Implementing home blood pressure monitoring into clinical practice. Curr Hypertens Rep. 2019;21:1\u201314.","journal-title":"Curr Hypertens Rep"},{"key":"1081_CR97","doi-asserted-by":"crossref","unstructured":"Rosenthal SR, Zhou J, Booth ST. Association between mobile phone screen time and depressive symptoms among college students: A threshold effect. Hum Behav Emerg Technol. 2021;3:432\u201340.","DOI":"10.1002\/hbe2.256"},{"key":"1081_CR98","doi-asserted-by":"publisher","first-page":"e8059","DOI":"10.2196\/resprot.8059","volume":"6","author":"LR Buis","year":"2017","unstructured":"Buis LR, Roberson DN, Kadri R, Rockey NG, Plegue MA, Choe HM, et al. Utilizing consumer health informatics to support management of hypertension by clinical pharmacists in primary care: study protocol. JMIR Res Protoc. 2017;6:e8059.","journal-title":"JMIR Res Protoc"},{"key":"1081_CR99","doi-asserted-by":"publisher","first-page":"e19882","DOI":"10.2196\/19882","volume":"22","author":"LR Buis","year":"2020","unstructured":"Buis LR, Roberson DN, Kadri R, Rockey NG, Plegue MA, Danak SU, et al. Understanding the feasibility, acceptability, and efficacy of a clinical pharmacist-led mobile approach (BPTrack) to hypertension management: mixed methods pilot study. J Med Internet Res. 2020;22:e19882.","journal-title":"J Med Internet Res"},{"key":"1081_CR100","first-page":"100083","volume":"4","author":"SI Mohiuddin","year":"2021","unstructured":"Mohiuddin SI, Thorakkattil SA, Abushoumi F, Nemr HS, Jabbour R, Al-Ghamdi F. Implementation of pharmacist-led tele medication management clinic in ambulatory care settings: a patient-centered care model in COVID-19 era. Explor Res Clin Soc Pharm. 2021;4:100083.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"1081_CR101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.amjcard.2023.06.109","volume":"203","author":"N Baral","year":"2023","unstructured":"Baral N, Volgman AS, Seri A, Chelikani V, Isa S, Javvadi SLP, et al. Adding pharmacist-led home blood pressure telemonitoring to usual care for blood pressure control: a systematic review and meta-analysis. Am J Cardiol. 2023;203:161\u20138.","journal-title":"Am J Cardiol"},{"key":"1081_CR102","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1002\/phar.2071","volume":"38","author":"ME Badowski","year":"2018","unstructured":"Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, et al. Providing comprehensive medication management in telehealth. Pharmacotherapy. 2018;38:e7\u2013e16.","journal-title":"Pharmacotherapy"},{"key":"1081_CR103","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.japh.2019.01.004","volume":"59","author":"JW Baker","year":"2019","unstructured":"Baker JW, Forkum W, McNeal J. Utilizing clinical video telehealth to improve access and optimize pharmacists\u2019 role in diabetes management. J Am Pharm Assoc. 2019;59:S63\u2013S66.","journal-title":"J Am Pharm Assoc"},{"key":"1081_CR104","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/pharmacy7040158","volume":"7","author":"J Cole","year":"2019","unstructured":"Cole J, Wilkins N, Moss M, Fu D, Carson P, Xiong L. Impact of pharmacist involvement on telehealth transitional care management (TCM) for high medication risk patients. Pharmacy. 2019;7:158.","journal-title":"Pharmacy"},{"key":"1081_CR105","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.18549\/PharmPract.2020.3.1926","volume":"18","author":"S Baldoni","year":"2020","unstructured":"Baldoni S, Pallotta G, Traini E, Sagaro GG, Nittari G, Amenta F. A survey on feasibility of telehealth services among young Italian pharmacists. Pharmacy Practice (Granada). 2020;18:1926.","journal-title":"Pharmacy Practice (Granada)"},{"key":"1081_CR106","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ijpp.12340","volume":"25","author":"R Kayyali","year":"2017","unstructured":"Kayyali R, Hesso I, Mahdi A, Hamzat O, Adu A, Nabhani Gebara S. Telehealth: misconceptions and experiences of healthcare professionals in England. Int J Pharm Pract. 2017;25:203\u20139.","journal-title":"Int J Pharm Pract"},{"key":"1081_CR107","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1357633X20916567","volume":"26","author":"AC Smith","year":"2020","unstructured":"Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;26:309\u201313.","journal-title":"J Telemed Telecare"},{"key":"1081_CR108","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3389\/fphar.2018.00678","volume":"9","author":"D Baines","year":"2018","unstructured":"Baines D, Gahir IK, Hussain A, Khan AJ, Schneider P, Hasan SS, et al. A scoping review of the quality and the design of evaluations of mobile health, telehealth, smart pump and monitoring technologies performed in a pharmacy-related setting. Front Pharmacol. 2018;9:678.","journal-title":"Front Pharmacol"},{"key":"1081_CR109","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2146\/ajhp130750","volume":"72","author":"LG Singh","year":"2015","unstructured":"Singh LG, Accursi M, Black KK. Implementation and outcomes of a pharmacist-managed clinical video telehealth anticoagulation clinic. Am J Health Syst Pharm. 2015;72:70\u201373.","journal-title":"Am J Health Syst Pharm"},{"key":"1081_CR110","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11239-018-1609-2","volume":"45","author":"M Lee","year":"2018","unstructured":"Lee M, Wang M, Liu J, Holbrook A. Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis. J Thromb Thrombolysis. 2018;45:325\u201336.","journal-title":"J Thromb Thrombolysis"},{"key":"1081_CR111","doi-asserted-by":"publisher","first-page":"1091484","DOI":"10.3389\/fpubh.2022.1091484","volume":"10","author":"X Li","year":"2022","unstructured":"Li X, Hu J, Yao Y, Zuo C, Wang Z, Li X, et al. Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: a pilot study. Front Public Health. 2022;10:1091484.","journal-title":"Front Public Health"},{"key":"1081_CR112","first-page":"63","volume":"22","author":"SM Abughosh","year":"2016","unstructured":"Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, et al. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a medicare advantage plan. J Manag Care Spec Pharm. 2016;22:63\u201373.","journal-title":"J Manag Care Spec Pharm"},{"key":"1081_CR113","first-page":"63","volume":"7","author":"MP Schneider","year":"2009","unstructured":"Schneider MP, Krummenacher I, Figueiredo H, Marquis J, Bugnon O. Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract. 2009;7:63.","journal-title":"Pharm Pract"},{"key":"1081_CR114","first-page":"2034, 2036","volume":"4","author":"P Schaller","year":"2008","unstructured":"Schaller P, Gaspoz J-M. Continuity, coordination and integration of care: from theory to practice. Rev Med Suisse. 2008;4:2034, 2036\u20139.","journal-title":"Rev Med Suisse"},{"key":"1081_CR115","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/qshc.2008.026435","volume":"19","author":"LM Holden","year":"2010","unstructured":"Holden LM, Watts D, Walker P. Communication and collaboration: it\u2019s about the pharmacists, as well as the physicians and nurses. BMJ Qual Saf. 2010;19:169\u201372.","journal-title":"BMJ Qual Saf"},{"key":"1081_CR116","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.pec.2018.01.022","volume":"101","author":"J Celio","year":"2018","unstructured":"Celio J, Ninane F, Bugnon O, Schneider MP. Pharmacist-nurse collaborations in medication adherence-enhancing interventions: a review. Patient Educ Couns. 2018;101:1175\u201392.","journal-title":"Patient Educ Couns"},{"key":"1081_CR117","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00228-012-1419-y","volume":"69","author":"YP Van Camp","year":"2013","unstructured":"Van Camp YP, Van Rompaey B, Elseviers MM. Nurse-led interventions to enhance adherence to chronic medication: systematic review and meta-analysis of randomised controlled trials. Eur J Clin Pharmacol. 2013;69:761\u201370.","journal-title":"Eur J Clin Pharmacol"},{"key":"1081_CR118","first-page":"CD000011","volume":"2014","author":"R Nieuwlaat","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014:CD000011.","journal-title":"Cochrane Database Syst Rev"},{"key":"1081_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-017-0677-2","volume":"19","author":"AM Tourkmani","year":"2018","unstructured":"Tourkmani AM, Abdelhay O, Alkhashan HI, Alaboud AF, Bakhit A, Elsaid T, et al. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study. BMC Fam Pract. 2018;19:1\u201310.","journal-title":"BMC Fam Pract"},{"key":"1081_CR120","first-page":"e010396","volume":"17","author":"KT Mills","year":"2024","unstructured":"Mills KT, O\u2019Connell SS, Pan M, Obst KM, He H, He J. Role of health care professionals in the success of blood pressure control interventions in patients with hypertension: a meta-analysis. Circ: Cardiovasc Qual Outcomes. 2024;17:e010396.","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"key":"1081_CR121","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","volume":"77","author":"G Parati","year":"2021","unstructured":"Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77:692\u2013705.","journal-title":"Hypertension"},{"key":"1081_CR122","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","volume":"79","author":"NK Choudhry","year":"2022","unstructured":"Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79:e1\u2013e14.","journal-title":"Hypertension"},{"key":"1081_CR123","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/cts.12979","volume":"14","author":"J Sung","year":"2021","unstructured":"Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, et al. Adherence to triple\u2010component antihypertensive regimens is higher with single\u2010pill than equivalent two\u2010pill regimens: a randomized controlled trial. Clin Transl Sci. 2021;14:1185\u201392.","journal-title":"Clin Transl Sci"},{"key":"1081_CR124","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","volume":"400","author":"IS Mackenzie","year":"2022","unstructured":"Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400:1417\u201325.","journal-title":"Lancet"},{"key":"1081_CR125","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/HYPERTENSIONAHA.120.16500","volume":"78","author":"RC Hermida","year":"2021","unstructured":"Hermida RC, Moj\u00f3n A, Smolensky MH, Fern\u00e1ndez JR. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension\u2014pro side of the argument. Hypertension. 2021;78:879\u201393.","journal-title":"Hypertension"},{"key":"1081_CR126","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/ijerph19074156","volume":"19","author":"M Paczkowska-Walendowska","year":"2022","unstructured":"Paczkowska-Walendowska M, Sip S, Staszewski R, Cielecka-Piontek J. Single-pill combination to improve hypertension treatment: pharmaceutical industry development. Int J Environ Res Public Health. 2022;19:4156.","journal-title":"Int J Environ Res Public Health"},{"key":"1081_CR127","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1331\/JAPhA.2008.08514","volume":"48","author":"A Burns","year":"2008","unstructured":"Burns A. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48:341\u201353.","journal-title":"J Am Pharm Assoc"},{"key":"1081_CR128","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/pharmacy11010037","volume":"11","author":"EI Rojas","year":"2023","unstructured":"Rojas EI, Dupotey NM, De Loof H. Comprehensive medication management services with a holistic point of view, a scoping review. Pharmacy. 2023;11:37.","journal-title":"Pharmacy"},{"key":"1081_CR129","first-page":"688","volume":"25","author":"E Ferries","year":"2019","unstructured":"Ferries E, Dye JT, Hall B, Ndehi L, Schwab P, Vaccaro J. Comparison of medication therapy management services and their effects on health care utilization and medication adherence. J Manag Care Spec Pharm. 2019;25:688\u201395.","journal-title":"J Manag Care Spec Pharm"},{"key":"1081_CR130","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.sapharm.2009.11.008","volume":"6","author":"ME Snyder","year":"2010","unstructured":"Snyder ME, Zillich AJ, Primack BA, Rice KR, Somma McGivney MA, Pringle JL, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010;6:307\u201323.","journal-title":"Res Social Adm Pharm"},{"key":"1081_CR131","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","volume":"134","author":"MS McFarland","year":"2021","unstructured":"McFarland MS, Buck ML, Crannage E, Armistead LT, Ourth H, Finks SW, et al. Assessing the impact of comprehensive medication management on achievement of the quadruple aim. Am J Med. 2021;134:456\u201361.","journal-title":"Am J Med"},{"key":"1081_CR132","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11096-007-9151-x","volume":"30","author":"CN Aguwa","year":"2008","unstructured":"Aguwa CN, Ukwe CV, Ekwunife OI. Effect of pharmaceutical care programme on blood pressure and quality of life in a nigerian pharmacy. Pharm World Sci. 2008;30:107\u201310.","journal-title":"Pharm World Sci"},{"key":"1081_CR133","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1345\/aph.1D605","volume":"38","author":"P Sookaneknun","year":"2004","unstructured":"Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C, et al. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023\u20138.","journal-title":"Ann Pharmacother"},{"key":"1081_CR134","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/jhh.2010.133","volume":"26","author":"F Alhalaiqa","year":"2012","unstructured":"Alhalaiqa F, Deane KH, Nawafleh AH, Clark A, Gray R. Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial. J Hum Hypertens. 2012;26:117\u201326.","journal-title":"J Hum Hypertens"},{"key":"1081_CR135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.22159\/ajpcr.2022.v15i5.43630","volume":"15","author":"AS Mathews","year":"2022","unstructured":"Mathews AS, Kumari S. Impact of pharmacist LED hypertension management. Asian J Pharm Clin Res. 2022;15:23\u201326.","journal-title":"Asian J Pharm Clin Res"},{"key":"1081_CR136","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jcph.101","volume":"53","author":"MC Wong","year":"2013","unstructured":"Wong MC, Liu KQ, Wang HH, Lee CL, Kwan MW, Lee KW, et al. Effectiveness of a pharmacist\u2010led drug counseling on enhancing antihypertensive adherence and blood pressure control: a randomized controlled trial. J Clin Pharmacol. 2013;53:753\u201361.","journal-title":"J Clin Pharmacol"},{"key":"1081_CR137","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4140\/TCP.n.2015.710","volume":"30","author":"AM Moultry","year":"2015","unstructured":"Moultry AM, Pounds K, Poon IO. Managing medication adherence in elderly hypertensive patients through pharmacist home visits. Consult Pharm. 2015;30:710\u20139.","journal-title":"Consult Pharm"},{"key":"1081_CR138","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/archinternmed.2010.390","volume":"171","author":"RG Victor","year":"2011","unstructured":"Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171:342\u201350.","journal-title":"Arch Intern Med"},{"key":"1081_CR139","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","volume":"378","author":"RG Victor","year":"2018","unstructured":"Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, et al. A cluster-randomized trial of blood-pressure reduction in black barbershops. N Engl J Med. 2018;378:1291\u2013301.","journal-title":"N Engl J Med"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01081-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01081-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01081-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:02:05Z","timestamp":1765184525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01081-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":139,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01081-x","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}